Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
SINTX TECHNOLOGIES ANNOUNCES EXPIRATION OF OVERSUBSCRIBED RIGHTS OFFERING
-
SINTX TECHNOLOGIES ANNOUNCES EXPIRATION OF OVERSUBSCRIBED RIGHTS OFFERING
-
Titan Medical Issues Letter to Shareholders
-
Coffee Holding Co. (JVA) PT Lowered to $7 at Maxim Group
-
Chipotle Mexican Grill (CMG) PT Raised to $920 at Maxim Group
-
Thompson Creek Metals (TC) PT Lowered to $3 at Maxim Group
-
Milestone Scientific (MLSS) PT Raised to $3 at Maxim Group
-
Maxim Group Upgrades Capricor Therapeutics (CAPR) to Buy
-
Nephros, Inc. (NEPH) Prices 937.5K Share Common Offering at $8/Sh
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
-
Fastbase Inc. 2020 - Further Advances into AI and Data Driven Marketing Automation
-
AGNC Investment Corp (AGNC) PT Raised to $19 at Maxim Group
-
Tetra Tech (TTEK) PT Raised to $110 at Maxim Group
-
Maxim Group Downgrades BioPharmX Corp (BPMX) to Hold
-
Maxim Group Upgrades Apple (AAPL) to Hold
-
Co-Diagnostics Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market
-
SVB Financial (SIVB) PT Raised to $300 at Maxim Group
-
Ionix Technology Engages Maxim Group to Assist with its Growth Strategy and Up-list to a National Exchange
-
Ionix Technology Engages Maxim Group to Assist with its Growth Strategy and Up-list to a National Exchange
-
Co-Diagnostics (CODX) $5 Million Registered Direct Offering of Common Stock
-
Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market
-
ToughBuilt Industries (TBLT) Prices Upsized $9 Million Underwritten Public Offering of Common Stock, Warrants
-
Toughbuilt Announces Pricing of Upsized $9.0 Million Underwritten Public Offering
-
Toughbuilt Announces Pricing of Upsized $9.0 Million Underwritten Public Offering
-
Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division
-
SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD
-
SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD
-
Nicolet Bankshares (NCBS) PT Raised to $79 at Maxim Group
-
PlacementTracker Publishes 2019 PIPE and Private Placement Markets League Tables
-
Heat Biologics, Inc. Announces Closing of $7,000,000 Public Offering
-
RumbleOn, Inc. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
First Republic Bank (FRC) PT Raised to $130 at Maxim Group
-
Domino's Pizza (DPZ) PT Raised to $315 at Maxim Group
-
Heat Biologics (HTBX) Prices $7M Offering of Common Stock, Warrants
-
Heat Biologics, Inc. Prices $7,000,000 Public Offering
-
RumbleOn, Inc. Closes $10.26 Million Public Offering of Its Class B Common Stock and Private Placement of $8.75 Million Convertible Notes
-
Matinas BioPharma Announces Closing of Public Offering of Common Stock
-
Matinas BioPharma Announces Closing of Public Offering of Common Stock
-
RumbleOn Inc. (RMBL) Prices Offering of Class B Common Stock and Private Placement of $7.5 Million Convertible Notes
-
RumbleOn, Inc. Announces Pricing of Public Offering of its Class B Common Stock and Private Placement of $7.5 Million Convertible Notes
-
Matinas BioPharma (MTNB) Prices 32.26M Shares at $1.55
-
Matinas BioPharma Announces Pricing of Public Offering of Common Stock
-
Matinas BioPharma Announces Pricing of Public Offering of Common Stock
-
Saratoga Investment (SAR) PT Raised to $29 at Maxim Group, Following Earnings Release
-
SELLAS Life Sciences (SLS) Prices $6.5M Registered Direct Share Offering Priced At-The-Market
-
SELLAS Announces Pricing of $6.5 Million Registered Direct Offering Priced At-The-Market
-
Maxim Group Upgrades Venus Concept Inc. (VERO) to Buy
-
Maxim Group Starts Xenetic Biosciences (XBIO) at Buy

